SoniVie TIVUS System Receives FDA Breakthrough Device Designation

TIVUS is a dedicated therapeutic ultrasound catheter to enhance the treatment of PAH and is inserted into the pulmonary artery during a right heart catheterization procedure. It is designed to ablate nerves associated with disease activity without damaging the vessel walls or the adjacent tissues to improve quality of life and clinical outcomes.

Sourced through Scoop.it from: www.mpo-mag.com